Evidence map›Paper›PMID 31260712›Full record

ReviewAdvanced drug delivery reviews2019

Careers in nanomedicine and drug delivery.

Elizabeth Nance

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advanced drug delivery reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. "Biomaterials translational · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Nanoporous Silicon as a Green, High-Tech Educational Tool.Nanomaterials (Basel, Switzerland) · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Elizabeth NanceDepartment of Chemical Engineering, University of Washington, Seattle, WA, United States of America; Department of Radiology, University of Washington, Seattle, WA, United States of America; Center on Human Development & Disability, University of Washington, Seattle, WA, United States of America; eScience Institute, Seattle, WA, United States of America; Molecular Engineering and Sciences Institute, University of Washington, Seattle, WA, United States of America. Electronic address: eanance@uw.edu.

Funding

Quantitative 3D imaging of in situ nanoparticle movement and cellular behavior during neuroinflammationR35GM124677 · NIGMS · UNIVERSITY OF WASHINGTON · PI NANCE, ELIZABETH A · 2017 to 2022
$2.5M
NIGMS NIH HHS R35 GM124677
6 · The paper itself

Abstract

Nanomedicine continues to be a rapidly growing and increasingly interdisciplinary field. The career opportunities available in nanomedicine are also numerous, yet not always obvious to the early-career scientist determining their individual track for maximal impact. This perspective provides a brief overview of the field of nanomedicine, then delves into the many career trajectories one could take in this field. The article concludes with thoughts on how to provide diverse training to increase supply for the variety of career paths, and the role that mentors can play in young scientists' development and exploration of these career paths.

Indexed as

NanomedicineCareer ChoiceDrug Delivery SystemsHumansMentoringConsultingMentoringNanotechnologyPolicyScience writingStartupTranslational medicine

Identifiers

PMID31260712
PMCPMC6745252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.